Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $9.22 and last traded at $9.22, with a volume of 20200 shares trading hands. The stock had previously closed at $10.51.
Ono Pharmaceutical Stock Performance
The company's fifty day simple moving average is $10.38 and its 200 day simple moving average is $12.49. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.22 and a quick ratio of 2.80. The firm has a market capitalization of $4.33 billion, a PE ratio of 6.88 and a beta of 0.59.
Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 11.85% and a net margin of 19.64%.
Ono Pharmaceutical Company Profile
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Further Reading
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
